Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections

Chao Zhang(Fudan University), Zhong Huang(Shenzhen University), Qiang Deng(Kunming University of Science and Technology), Yanxing Wang(Chinese Academy of Sciences), Wenyu Han(Center for Excellence in Molecular Cell Science), Shiqi Xu(Institut Pasteur of Shanghai), Dimitri Lavillette(Soochow University), Shutian Wang(The Synergetic Innovation Center for Advanced Materials), Liangliang Kong(Jiangsu Province Hospital), Tingfeng Wang(Pudong Medical Center), Yuanfei Zhu(Shanghai Medical College of Fudan University), Jinkai Zang(The Ohio State University), Yong Yang(Chinese Academy of Sciences), Fangfang Wang(Shenzhen Sixth People's Hospital), Yifan Wang(Chinese Academy of Sciences), Youhua Xie(Shanghai Medical College of Fudan University), Yao Cong(Center for Excellence in Molecular Cell Science), Chenjian Gu(Washington University in St. Louis), Cong Xu(Chinese Academy of Sciences), Xueyang Zhang(Tsinghua University), Yalei Wang(Institut Pasteur of Shanghai), Xiaoyu Hong(Shanghai Astronomical Observatory), Haikun Wang(Peking University), Hong Qin(Shanghai Clinical Research Center), Hong Tang(Sichuan Agricultural University), Weihua Qiao(Institut Pasteur of Shanghai), Di Qu(Xijing Hospital), Caixuan Liu(Chinese Academy of Sciences), Qiaoyu Zhao(Center for Excellence in Molecular Cell Science), Yu Zhou(Yangtze University)
Nature Communications
January 11, 2021
Cited by 108


Related Papers